Ketoprofene Medisol (Ketoprofen)

Ketoprofen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins. Lower prostaglandin levels diminish inflammation, pain signalling and fever, producing the drug’s analgesic, anti‑inflammatory and antipyretic actions.

The appropriate dose of Ketoprofene Medisol is determined by the prescribing clinician based on the patient’s condition, severity of pain, weight, renal and hepatic function, and any concomitant therapies. Dosing regimens are individualized and should follow the prescriber’s instructions.

Safety data for ketoprofen in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It is generally avoided unless the potential benefit outweighs the risk, and breastfeeding mothers should consult their healthcare provider before use.

To order Ketoprofene Medisol, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and any necessary import documentation.

Ketoprofene Medisol belongs to the same class of non‑steroidal anti‑inflammatory drugs as ibuprofen, diclofenac and naproxen. Compared with some oral NSAIDs, the intravenous route offers faster onset of action and more predictable plasma levels, which can be advantageous in acute postoperative settings.

Ketoprofene Medisol should be stored at 2‑8 °C in a refrigerator, protected from light. The solution must not be frozen or shaken vigorously. If temperature excursions occur, the product should be inspected for clarity and used only if it remains within specifications.

Ketoprofene Medisol is administered intravenously by a qualified healthcare professional. The prescriber determines the infusion rate and total dose, which is typically delivered over a short period to achieve rapid analgesia. Administration should follow aseptic technique and institutional infusion guidelines.

Serious risks include gastrointestinal bleeding or ulcer perforation, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, and acute renal failure. Patients should be monitored for signs of bleeding, rash, respiratory distress or sudden changes in kidney function during therapy.

Ketoprofene Medisol is contraindicated in patients with known hypersensitivity to ketoprofen or any NSAID, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, and in those with a history of severe cardiovascular events unless specifically directed by a physician.